2017
$25M
from 4 investors over 4 rounds
Nectin Therapeutics raised $25M on November 30, 2022
Investors: Peregrine Ventures
Nectin Therapeutics raised $5.4M on March 7, 2022
Investors: Cancer Focus Fund
Nectin Therapeutics raised $6M on July 14, 2020
Investors: aMoon Fund
Nectin Therapeutics raised undisclosed on January 1, 2017
Investors: Integra Holdings